R. Awasthi, E. Waldron, S.A. Grupp, M. A. Pulsipher, P. Bader, S. J. Schuster, R. Maziarz, E. Waller, U. Jager, C. Thieblemont, M. Dreyling, N. Fowler, H. J. Maier, J. Willert
{"title":"急性淋巴细胞白血病(all)、弥漫性大 B 细胞淋巴瘤(dlbcl)和滤泡性淋巴瘤(fl)复发/难治性(r/r)患者(pts)接受替沙根白细胞介素(tisagenlecleucel,tisa-cel)治疗后的长期持久反应及其与嵌合抗原受体(car)t 细胞持续存在的关系","authors":"R. Awasthi, E. Waldron, S.A. Grupp, M. A. Pulsipher, P. Bader, S. J. Schuster, R. Maziarz, E. Waller, U. Jager, C. Thieblemont, M. Dreyling, N. Fowler, H. J. Maier, J. Willert","doi":"10.1016/j.jcyt.2024.03.297","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":505215,"journal":{"name":"Cytotherapy","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"LONG-TERM DURABLE RESPONSES IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) ACUTE LYMPHOBLASTIC LEUKEMIA (ALL), DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL), AND FOLLICULAR LYMPHOMA (FL) TREATED WITH TISAGENLECLEUCEL (TISA-CEL) AND ITS ASSOCIATION WITH PERSISTENCE OF CHIMERIC ANTIGEN RECEPTOR (CAR) T CELL\",\"authors\":\"R. Awasthi, E. Waldron, S.A. Grupp, M. A. Pulsipher, P. Bader, S. J. Schuster, R. Maziarz, E. Waller, U. Jager, C. Thieblemont, M. Dreyling, N. Fowler, H. J. Maier, J. Willert\",\"doi\":\"10.1016/j.jcyt.2024.03.297\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":505215,\"journal\":{\"name\":\"Cytotherapy\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cytotherapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.jcyt.2024.03.297\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cytotherapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.jcyt.2024.03.297","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
LONG-TERM DURABLE RESPONSES IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) ACUTE LYMPHOBLASTIC LEUKEMIA (ALL), DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL), AND FOLLICULAR LYMPHOMA (FL) TREATED WITH TISAGENLECLEUCEL (TISA-CEL) AND ITS ASSOCIATION WITH PERSISTENCE OF CHIMERIC ANTIGEN RECEPTOR (CAR) T CELL